305 related articles for article (PubMed ID: 27717198)
41. [Next generation sequencing].
Le Mercier M; D'Haene N; Rorive S; Degand C; De Nève N; Blanchard O; Salmon I
Rev Med Brux; 2016; 37(5):436-438. PubMed ID: 28525213
[TBL] [Abstract][Full Text] [Related]
42. Application of biomarkers in the diagnosis of uncertain samples of core needle biopsy of thyroid nodules.
Xiong Y; Li X; Liang L; Li D; Yan L; Li X; Di J; Li T
Virchows Arch; 2021 Nov; 479(5):961-974. PubMed ID: 34308507
[TBL] [Abstract][Full Text] [Related]
43. Local molecular analysis of indeterminate thyroid nodules.
Gill MS; Nayan S; Kocovski L; Cutz JC; Archibald SD; Jackson BS; Young JE; Gupta MK
J Otolaryngol Head Neck Surg; 2015 Dec; 44():52. PubMed ID: 26621130
[TBL] [Abstract][Full Text] [Related]
44. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population.
Kim SW; Lee JI; Kim JW; Ki CS; Oh YL; Choi YL; Shin JH; Kim HK; Jang HW; Chung JH
J Clin Endocrinol Metab; 2010 Aug; 95(8):3693-700. PubMed ID: 20501689
[TBL] [Abstract][Full Text] [Related]
45. Multiplex PCR approach to simultaneously identify several mutations in fine needle cytology thyroid samples.
Vuttariello E; Borra M; Mauriello E; Calise C; D'Andrea B; Capiluongo A; Fulciniti F; Cipolletta A; Monaco M; Pezzullo L; Chiappetta G
Oncotarget; 2017 Jul; 8(30):49351-49358. PubMed ID: 28537891
[TBL] [Abstract][Full Text] [Related]
46. [The value of multi-gene testing in benign or malign diagnosis of thyroid nodules with indeterminate cytology].
Song YT; Xu GH; Zhu YL; Ma TH; Yu H; Wang TX; Yu WB; Wei W; Zhang B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 54(10):764-768. PubMed ID: 31606990
[No Abstract] [Full Text] [Related]
47. The utility of molecular markers in pre-operative assessment of thyroid nodules.
Bhatia P; Abd Elmageed ZY; Friedlander P; Aslam R; Kandil E
Future Oncol; 2015; 11(16):2343-50. PubMed ID: 26260812
[TBL] [Abstract][Full Text] [Related]
48. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
[TBL] [Abstract][Full Text] [Related]
49. Development and Analytical Validation of an Expanded Mutation Detection Panel for Next-Generation Sequencing of Thyroid Nodule Aspirates.
Ablordeppey KK; Timmaraju VA; Song-Yang JW; Yaqoob S; Narick C; Mireskandari A; Finkelstein SD; Kumar G
J Mol Diagn; 2020 Mar; 22(3):355-367. PubMed ID: 31866571
[TBL] [Abstract][Full Text] [Related]
50. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
[TBL] [Abstract][Full Text] [Related]
51. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
[TBL] [Abstract][Full Text] [Related]
52. Incidence and predictive factors of inadequate fine-needle aspirates for BRAF(V600E) mutation analysis in thyroid nodules.
Lee KH; Kim HS; Han BK; Ko EY; Ki CS; Shin JH
AJR Am J Roentgenol; 2014 Feb; 202(2):391-6. PubMed ID: 24450682
[TBL] [Abstract][Full Text] [Related]
53. A comparison of DP-TOF Mass Spectroscopy (MS) and Next Generation Sequencing (NGS) methods for detecting molecular mutations in thyroid nodules fine needle aspiration biopsies.
Qian XQ; Agyekum EA; Zhao LL; Yu RL; Li XY; Gu DJ; Yan N; Xu M; Yuan Y; Wang YG; Xin-Ping W; Xu FJ
Front Endocrinol (Lausanne); 2022; 13():928788. PubMed ID: 35992139
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of 167 Gene Expression Classifier (GEC) and ThyroSeq v2 Diagnostic Accuracy in the Preoperative Assessment of Indeterminate Thyroid Nodules: Bivariate/HROC Meta-analysis.
Borowczyk M; Szczepanek-Parulska E; Olejarz M; Więckowska B; Verburg FA; Dębicki S; Budny B; Janicka-Jedyńska M; Ziemnicka K; Ruchała M
Endocr Pathol; 2019 Mar; 30(1):8-15. PubMed ID: 30591992
[TBL] [Abstract][Full Text] [Related]
55. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?
Kloos RT; Reynolds JD; Walsh PS; Wilde JI; Tom EY; Pagan M; Barbacioru C; Chudova DI; Wong M; Friedman L; LiVolsi VA; Rosai J; Lanman RB; Kennedy GC
J Clin Endocrinol Metab; 2013 Apr; 98(4):E761-8. PubMed ID: 23476074
[TBL] [Abstract][Full Text] [Related]
56. Endoscopic ultrasound fine-needle aspiration cytology mutation profiling using targeted next-generation sequencing: personalized care for rectal cancer.
Gleeson FC; Kipp BR; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Sciallis AP; Graham RP; Lazaridis KN; Henry MR; Levy MJ
Am J Clin Pathol; 2015 Jun; 143(6):879-88. PubMed ID: 25972331
[TBL] [Abstract][Full Text] [Related]
57. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
[TBL] [Abstract][Full Text] [Related]
58. Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay.
Picarsic JL; Buryk MA; Ozolek J; Ranganathan S; Monaco SE; Simons JP; Witchel SF; Gurtunca N; Joyce J; Zhong S; Nikiforova MN; Nikiforov YE
Pediatr Dev Pathol; 2016; 19(2):115-22. PubMed ID: 26367451
[TBL] [Abstract][Full Text] [Related]
59. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
60. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
Karnes HE; Duncavage EJ; Bernadt CT
Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
